November 18, 2026
Health news, explained with evidence
LIVE
Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia

Common Heart Biomarker May Actively Drive Dangerous Blood Clots, Study Finds

🔬 Research 2 min read 👁 5

New research from Texas A&M Health reveals that the hormone BNP, traditionally viewed merely as a warning sign of cardiac stress, actively promotes blood clotting.

Common Heart Biomarker May Actively Drive Dangerous Blood Clots, Study Finds🔬Research

Photo: Medical Xpress

Key points

  • BNP actively drives platelet aggregation rather than just acting as a passive warning marker.
  • The hormone binds to the NPRA receptor on platelets, triggering a chain reaction that accelerates clot formation.
  • Blocking this specific receptor prevented abnormal clotting in experimental models without impairing general healing.

Heart failure remains a leading health challenge across the United States, prompting physicians to regularly monitor a specific hormone known as B-type natriuretic peptide, or BNP. Elevated concentrations of this peptide have long functioned as a biological indicator, signaling to medical providers that the heart muscle is experiencing excessive strain. However, a recent investigation led by scientists at the Texas A&M University Irma Lerma Rangel College of Pharmacy suggests this molecule may play a much more active role in cardiovascular deterioration.

Published in the Blood Journal, the findings indicate that high levels of BNP stimulate blood platelets to clump together, thereby accelerating dangerous blockages inside blood vessels. According to the study, the hormone binds directly to a specialized surface protein on platelets called natriuretic peptide receptor-A, or NPRA. This interaction triggers an internal molecular reaction that elevates signaling molecules within the platelets, promoting hyperactive clotting behaviors that can heighten the risk of heart attacks and pulmonary embolisms.

While this discovery sheds light on why patients with elevated peptide levels face severe cardiovascular risks, the authors note that the work is based on laboratory and biological mechanisms rather than a full clinical trial. Experts emphasize that more research is needed to translate these insights into human treatments. What to know: Blocking the NPRA receptor prevented abnormal clot formation in experimental settings, offering a potential target for future medications that could avoid the bleeding risks associated with standard antiplatelet drugs. Always consult a qualified healthcare provider for personal medical decisions and cardiovascular management.

Source Medical Xpress — medicalxpress.com/news/2026-11-common-cardiovascular-biomarker-contribu… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.